Thanks to medical advances, patients are increasingly and safely undergoing a broad range of surgical procedures outside hospitals’ traditional four walls. In fact, two of every three surgeries performed by our member hospitals are now done on an outpatient basis. That’s why recent reports of some employers trying to exclude outpatient surgeries from employer-sponsored health plans are so alarming. These so-called “skinny plans” deny consumers’ important medical choices and can discourage patients from seeking needed care. “Skinny plans,” in short, run contrary to the Affordable Care Act’s promise of comprehensive, affordable coverage. This week, the AHA weighed-in on the controversy, and strongly urged swift action by the Centers for Medicare & Medicaid Services and the Department of the Treasury to protect consumers from limited benefit plans. This builds on AHA’s successful work in 2014 to correct “skinny plans” attempting to exclude needed inpatient coverage. It also reflects our continuing commitment to securing patient access to a comprehensive range of benefits so patients can get the care they need. 

Related News Articles

Headline
The AHA today released the Health Plan Accountability Update for the third quarter of 2025. The update covers the latest developments in Medicare…
Headline
The AHA Oct. 3 responded to the Medicare Payment Advisory Commission’s recent analysis on the financial impacts of Medicare Advantage enrollment growth on…
Headline
A JAMA study published yesterday analyzed the health characteristics of individuals projected to lose Medicaid coverage due to work requirements included in…
Headline
The Centers for Medicare & Medicaid Services Sept. 30 released guidance to states clarifying its interpretation of a provision that…
Headline
An analysis published Sept. 30 by KFF found that Health Insurance Marketplace enrollees who currently benefit from the enhanced premium tax credits would pay…
Headline
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by…